Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. New research suggests prolonged GLP-1 use may be linked ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. The injectable ...

We are making a handful of trades on Wednesday. We're buying 30 shares of Capital One Financial at roughly $208 each, increasing the weighting in Jim Cramer's Charitable Trust to 3.05% from 2.9% and ...

BEIJING, Feb 14 (Reuters) - China will implement zero‑tariff treatment for imports from the 53 African countries with which it has diplomatic relations, starting May 1, 2026, state media reported on ...

More than 1 in 8 American adults are using GLP-1’s for weight loss. Experts say these are the nutritional gaps and side effects that should not to be overlooked. As GLP-1 medications continue to ...

As GLP-1s continue to surge in demand, older patients in your practice may inquire about these medications for their weight-loss efforts. Although they are known to improve conditions such as high ...

Research shows that practicing these two key sleep hygiene roles every night can help you live longer When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...

Passengers traveling out of Detroit Metro Airport without REAL ID will have an option to pay $45 under the TSA’s new identity verification system The Transportation Security Administration’s new ...

A sizable percentage of people using Novo (NVO) and Lilly’s (LLY) GLP-1 drugs may be able to sustain their weight loss effects even months after discontinuing the popular obesity drugs, Reuters ...

X is putting its money where its mouth is. The Elon Musk-owned social media platform just pledged it will give $1 million to the user who creates the most popular long-form post using its newly ...

Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...

On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will collaborate with the new venture to develop technology to link ...